Article Text
Abstract
Risk–benefit assessment is a routine requirement for research ethics committees that review and oversee biomedical research with human subjects. Nevertheless, it remains unclear how to weigh and balance risks to research participants against the social benefits that flow from generating biomedical knowledge. In this article, we address the question of whether there are any reasonable criteria for defining the limit of permissible risks to individuals who provide informed consent for research participation. We argue against any a priori limit to permissible research risks. However, attention to the uncertainty of potential social benefit that can be derived from any particular study warrants caution in exposing prospective research participants to a substantial likelihood of serious harm.
Statistics from Altmetric.com
Linked Articles
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Assessing research risks systematically: the net risks test
- Individual risk and community benefit in international research
- Risk, double effect and the social benefit requirement
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- “Fair’s fair argument” and voluntarism in clinical research: But, is it fair?
- Can informed consent to research be adapted to risk?
- When to start paediatric testing of the adult HIV cure research agenda?
- The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens
- Children in health research: a matter of trust
- Process of risk assessment by research ethics committees: foundations, shortcomings and open questions